@extremetech.com 1 year ago
FDA Reportedly Rejected Elon Musk’s Neuralink Brain Chip Trial Over Safety Risks
@xconomy.com 3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures